Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Poland Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20062
20074
20082
20096
20101
20113
20122
20131
20141
20151
20161
20182
20203
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Active, not recruiting4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Pfizer4
Amgen3
Bayer3
Merck KGaA, Darmstadt, Germany2
Ryvu Therapeutics SA2
AbbVie1
Astellas Pharma Inc1
Genentech, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis36
Breast Neoplasms13
Carcinoma, Non-Small-Cell Lung8
Neoplasms6
Colorectal Neoplasms5
Recurrence5
Lung Neoplasms3
Carcinoma, Renal Cell2
Colonic Neoplasms2
Kidney Neoplasms2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.